Fahad Benthani

3PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Feb 05, 2025
Author Correction: Virus-induced senescence is a driver and therapeutic target in COVID-19.

Soyoung Lee, Yong Yu, Jakob Trimpert

|Jun 24, 2022
<i>MCC</i> Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and Olaparib.

Zeenat Jahan, Fahad A Benthani, Nicola Currey

|Sep 13, 2021
Virus-induced senescence is a driver and therapeutic target in COVID-19.

Soyoung Lee, Yong Yu, Jakob Trimpert

Pageof 1

Frequent Collaborators

2 joint publications

Daniela Niemeyer

2 joint publications

Clemens A Schmitt

2 joint publications

Séverine Kunz

2 joint publications

Soyoung Lee

2 joint publications

Jakob Trimpert

2 joint publications

Emanuel Wyler

2 joint publications

Dimitri Belenki

2 joint publications

Theresa C Firsching

2 joint publications

Michael Schotsaert

2 joint publications

Carles Martínez-Romero

Frequent Collaborators

2 joint publications

Daniela Niemeyer

2 joint publications

Clemens A Schmitt

2 joint publications

Séverine Kunz

2 joint publications

Soyoung Lee

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
06:08

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

1.1K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.4K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on : Dec 23, 2020

6.3K
See more related videos

Top Related Videos

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies
06:08

Application of Ha-CoV-2 Pseudovirus for Rapid Quantification of SARS-CoV-2 Variants and Neutralizing Antibodies

Published on : Sep 08, 2023

1.1K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.4K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on : Dec 23, 2020

6.3K
See more related videos